跳至主要内容
临床试验/NCT01641913
NCT01641913已完成1 期

Determination of Intestinal Permeability and Response to Treatment in Patients With Eosinophilic Esophagitis

Mayo Clinic2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2012年8月最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
Mayo Clinic
入组人数
20
试验地点
2
主要终点
To assess patients gastrointestinal symptoms in patients with EoE by means of standard validated questionnaires

研究概览

简要总结

Do patient's with eosinophilic esophagitis have increased small intestinal permeability and if this changes in response to topically administered esophageal steroids?

详细描述

Eosinophilic esophagitis is an allergy mediated disease in which antigens exposed to the gastrointestinal tract trigger a combined immediate hypersensitivity.

The investigators anticipate that patients with active eosinophilic esophagitis will have increased intestinal permeability on urine collection of sugars. The investigators are not sure whether these findings will be found in patients who have been successfully treated with topical esophageal steroids. Improvement in intestinal permeability would be perceived as indicating that esophageal disease drives the intestinal permeability. Lack of improvement would indicate that eosinophilic esophagitis is a more systemic disease in which increased small bowel permeability is a marker or perhaps important driver of the disease.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects between the ages of 18 and 80 with Eosinophilic Esophagitis diagnosed by compatible symptoms, endoscopic findings, histology and lack of response to proton pump inhibitors or negative pH study.
  • Vulnerable populations, such as those with diminished mental acuity, will be excluded.
  • Patients allergic to Lactulose
  • Women who are pregnant or lactating.

排除标准

  • 未提供

结局指标

主要结局

To assess patients gastrointestinal symptoms in patients with EoE by means of standard validated questionnaires

时间窗: 30 days

heartburn, trouble swallowing

次要结局

  • To determine if patients with eosinophilic esophagitis have increased small intestinal permeability and if this changes in response to topically administered esophageal steroids.(2 hours)

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

David A. Katzka

Principal Investigator

Mayo Clinic

研究点 (2)

Loading locations...

相似试验